Main caricature of Melanie Matheu, who is speaking at HLTH and is CEO + Founder at Prellis Biologics, Inc. Overlay caricature of Melanie Matheu, who is speaking at HLTH and is CEO + Founder at Prellis Biologics, Inc.

Melanie Matheu

CEO + Founder

Prellis Biologics, Inc.

Dr. Matheu founded Prellis Biologics in October 2016 with a design for a laser-based non-cell toxic printing system on paper and a vision to create fully vascularized human tissues and organs for transplantation. Her realization that the tiny blood vessels necessary for creating human organs could be replicated using the technology at the center of her research, led to development of the blended engineering and biology approach Prellis is using to solve the human organ shortage.

Prellis Biologics has demonstrated the fastest high resolution 3D printing speeds to date, making vascularized organ and tissue engineering a reality.

Dr. Matheu’s vision is to shift the focus of health and medicine from palliative care to curative solutions, giving patients their lives back through production of organs and tissues that behave exactly like the patients native organs. Dr. Matheu obtained her PhD in Physiology and Biophysics from the University of California Irvine, where she worked on the first ever video-rate two photon microscope and has published numerous peer reviewed articles and protocols in the field of Immunology.

See All Speakers

Some additional speakers you may like

Chief Digital & Technology Officer
GSK
Chief Marketing Officer
Hims & Hers
Senior Advisor to the Secretary and Deputy Administrator of CMS and Director of the CMS Innovation Center
Center for Medicare and Medicaid Innovation
President and Chief Executive Officer
Highmark Health